Guillaume Canaud
2020. Our group is dedicated to deciphering the mechanisms underlying the pathophysiology of overgrowth syndromes and vascular abnormalities of genetic origin in order to propose new therapies to patients. We have been working for a long time on the PIK3/AKT/mTOR pathway in the context of renal diseases and have progressively...
22 January, 2020